Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
Fulcrum announced on September 12, 2024, that “its Phase 3 REACH trial evaluating losmapimod in patients with FSHD, did not achieve its primary endpoint of change from baseline in RSA with losmapimod compared to placebo. In addition, secondary endpoints did not achieve nominal statistical significance.”
Following this news, Fulcrum stock dropped 60% in morning trading on the same day.
Ticker Symbol | Company Name | Join Deadline | |
---|---|---|---|
CXM | Sprinklr, Inc. | October 15, 2024 | Join |
STLA | Stellantis N.V. | October 15, 2024 | Join |
SYM | Symbotic Inc. | October 15, 2024 | Join |
EXTR | Extreme Networks, Inc. | October 15, 2024 | Join |
PDD | PDD Holdings Inc. f/k/a Pinduoduo Inc. | October 15, 2024 | Join |
ARDX | Ardelyx, Inc. | October 15, 2024 | Join |
OFIX | Orthofix Medical Inc. | October 21, 2024 | Join |
DXCM | DexCom, Inc. | October 21, 2024 | Join |
SPIR | Spire Global, Inc. | October 21, 2024 | Join |
STM | STMicroelectronics N.V. | October 22, 2024 | Join |
DAVA | Endava plc | October 25, 2024 | Join |
MEI | Methode Electronics, Inc. | October 25, 2024 | Join |
SAGE | Sage Therapeutics, Inc. | October 28, 2024 | Join |
VERV | Verve Therapeutics, Inc. | October 28, 2024 | Join |
SBUX | Starbucks Corporation | October 28, 2024 | Join |
OM | Outset Medical, Inc. | October 28, 2024 | Join |
SMCI | Super Micro Computer, Inc. | October 29, 2024 | Join |
ZI | ZoomInfo Technologies Inc. | November 04, 2024 | Join |
WBTN | WEBTOON Entertainment Inc. | November 04, 2024 | Join |
GTLB | GitLab Inc. | November 04, 2024 | Join |
GTLB | GitLab Inc. | November 04, 2024 | Join |
AGEN | Agenus Inc. | November 05, 2024 | Join |
NFE | New Fortress Energy Inc. | November 18, 2024 | Join |
MGX | Metagenomi, Inc. | November 25, 2024 | Join |
BMBL | Bumble Inc. | November 25, 2024 | Join |